Net profit of Concord Drugs rose 300.00% to Rs 0.12 crore in the quarter ended June 2025 as against Rs 0.03 crore during the previous quarter ended June 2024. Sales rose 16.42% to Rs 13.61 crore in the quarter ended June 2025 as against Rs 11.69 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 13.61 | 11.69 | 16 |
| OPM % | 7.49 | 7.10 | - |
| PBDT | 0.53 | 0.38 | 39 |
| PBT | 0.16 | 0.04 | 300 |
| NP | 0.12 | 0.03 | 300 |